Back to Agendas
Recent Experiences with Adaptive Licensing and Facilitated Regulatory Pathways
Session Chair(s)
Lawrence Liberti, PhD, RAC
Director, D.K. Kim International Center for Regulatory Science
The Kim Center/ USC DRQS, United States
Facilitated regulatory pathways (FRPs) and transformative adaptive licensing (AL) procedures can accelerate patient access to medicines. This forum will review recent experiences, facilitators and how barriers have been overcome for effective use of FRPs and considerations for AL pilots.
Learning Objective : Discuss perspectives of stakeholders to the barriers and opportunities to using adaptive licensing (AL) or facilitated regulatory pathways (FRPs); Identify the characteristics that may contribute to a successful AL or FRP process; Describe results of the use of AL and FRP models in various jurisdictions.
Speaker(s)
Stakeholder Perceptions of Adaptive Licensing and Facilitated Regulatory Pathways (FRPs)
Lawrence Liberti, PhD, RAC
The Kim Center/ USC DRQS, United States
Director, D.K. Kim International Center for Regulatory Science
Marketing Authorizations for Earlier Patient Access: Regulatory Challenges in Japan
Daisaku Sato, PhD, MPharm, RPh
Ministry of Health, Labour and Welfare, Japan
Director, Compliance & Narcotics Division
Bringing Innovative Medicines to Patients and Maximizing Benefits to Public Health Through Adaptive Licensing
Hans-Georg Eichler, MD, MSc
Austrian Association of Social Security Bodies, Austria
Consulting Physician
Have an account?